|
MRFAP1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.035800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.321170E-03 |
| Normal-vs-Stage2 |
7.946300E-02 |
| Normal-vs-Stage3 |
2.659400E-03 |
| Normal-vs-Stage4 |
5.236200E-01 |
| Stage1-vs-Stage2 |
6.035200E-01 |
| Stage1-vs-Stage3 |
3.500800E-01 |
| Stage1-vs-Stage4 |
5.275400E-01 |
| Stage2-vs-Stage3 |
2.140800E-01 |
| Stage2-vs-Stage4 |
8.098800E-01 |
| Stage3-vs-Stage4 |
2.770000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.403600E-04 |
| Normal-vs-AfricanAmerican |
2.763900E-02 |
| Normal-vs-Asian |
3.719400E-01 |
| Caucasian-vs-AfricanAmerican |
4.944000E-01 |
| Caucasian-vs-Asian |
9.866200E-01 |
| AfricanAmerican-vs-Asian |
8.147400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.011900E-04 |
| Normal-vs-Female |
1.687890E-02 |
| Male-vs-Female |
5.410000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.809500E-02 |
| Normal-vs-Extreme_Weight |
3.241700E-03 |
| Normal-vs-Obese |
1.389840E-02 |
| Normal-vs-Extreme_Obese |
3.686200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.852200E-01 |
| Normal_Weight-vs-Obese |
7.316400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.462800E-01 |
| Extreme_Weight-vs-Obese |
6.532400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.456800E-01 |
| Obese-vs-Extreme_Obese |
7.482400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.089200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.630100E-02 |
| Normal-vs-Age(61-80Yrs) |
9.8849000000012E-05 |
| Normal-vs-Age(81-100Yrs) |
1.930490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.637200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.096400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.380000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.134400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.196560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.605200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.253800E-02 |
| Normal-VS-Type2 PRCC |
5.1966000003123E-07 |
| Normal-VS-KIRP CIMP |
5.551900E-04 |
| Normal-VS-Unclassified PRCC |
7.965700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.814900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.427600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.102000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.690400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.311700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.014200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.89640000000302E-05 |
| Normal-vs-N1 |
7.113000E-01 |
| Normal-vs-N2 |
4.238000E-04 |
| N0-vs-N1 |
5.158500E-02 |
| N0-vs-N2 |
1.050960E-01 |
| N1-vs-N2 |
8.576300E-02 |
|
|
